Human β-defensin 2 (hBD2) is an antimicrobial peptide believed to play an important role in the pathogenesis of psoriasis. IL-17A and TNFα play an important role in psoriasis and are known to synergistically upregulate a number of genes related to psoriasis, including hBD2. The purpose of this study was to characterize the mechanism by which IL-17A and TNFα mediate their synergistic effect on hBD2 expression. Treating cultured human keratinocytes with inhibitors before stimulation with IL-17A or TNFα alone, or in combination revealed that hBD2 expression was mediated by a p38 MAPK and NF-κB dependent mechanism. Gene reporter experiments demonstrated that a 384 bp promoter fragment of hBD2 was synergistically upregulated by IL-17A and TNFα. In this promoter fragment we identified binding sites for NF-κB, AP1, C/EBP and OCT1, all transcription factors previously described to play a potential role in IL-17A regulated gene expression. Interestingly, mutations of these binding sites revealed that NF-κB, AP1 and OCT1 were crucial for the IL-17A/TNFα-mediated hBD2 induction, because mutations in each of these individual binding sites completely abolished IL-17A/TNFα-induced hBD2 promoter activity. By mobility shift assay we found that the DNA binding activity of NF-κB was increased by TNFα, but not IL-17A, whereas there was a constitutive binding activity of OCT1 and AP1 to their binding sites. This activation was not regulated by TNFα or IL-17A. qPCR experiments revealed that mRNA expression of IκBζ, a NF-κB co-factor, was increased by IL-17A stimulation, but not by TNFα. Taken together this study identified the mechanism by which IL-17A and TNFα mediate their synergistic effect on hBD2 expression. TNFα induces activation and binding of NF-κB to the hBD2 promoter. Co-stimulation with IL-17A results in an accumulation of IκBζ which can act as a co-factor for NF-κB on the hBD2 promoter and thereby induce hBD2 expression. Moreover, constitutive binding of OCT1 and AP1 to the hBD2 promoter was crucial for IL-17A/TNFα-induced hBD2 expression. Recently, we identified insulin/IGF-1 signaling through regulation of the small GTPase Rac as key determinants of epidermal morphogenesis, stratification and proliferative potential. Here, we examined how insulin receptor (IR) and/or IGF-1 receptor (IGF-1R) signalling regulates epidermal morphogenesis and stratification. Epidermal loss of IR/IGF-1R triggered an increased stress response and spindle checkpoint arrest accompanied by a biased loss of asymmetric divisions at E16.5, when the phenotype is first microscopically apparent. This correlated with reduced p63 expression, a known regulator of epidermal asymmetric division and differentiation, and altered expression of several p63 targets. Insulin/IGF-1 signalling negatively regulate FoxO transcription factor activity and we thus hypothesized that FoxOs may either regulate p63 expression or counteract p63-mediated transcription. Using gene expression reporter assays, Co-IP, realtime PCR and ChIP analysis we found that upon loss of insulin/IGF-1 signaling FoxO translocates to the nucleus where it binds to p63 and negatively modulates p63 transcriptional activity. If insulin/IGF-1 control p63 mediated stratification through inhibition of FoxO, then one would predict that expression of a constitutive active FoxO would resemble loss of p63. Indeed, epidermal expression of such a mutant in mice leads to a one to two-layer epidermis, a lack of stratification, similar to p63 null mice. In contrast, epidermal expression of only the FoxO DNA binding domain did not interfere with epidermal morphogenesis, confirming our result that FoxO mediated regulation of p63 does not require DNA binding of FoxO. Since asymmetric cell divisions have been implicated in the regulation of epidermal stratification, the results indicate that epidermal insulin/IGF-1 signaling through FoxO dependent regulation of p63 activity couples cell cycle progression to spindle orientation thereby regulating the number of suprabasal layers in the IFE during morphogenesis. One of the major adverse effects of topical glucocorticoids is cutaneous atrophy. The molecular mechanisms underlying this phenomenon are poorly understood. To elucidate the mechanisms of epidermal hypoplasia, we used chronic topical treatment of mouse and human skin with glucocorticoids fluocinolone acetonide (FA) and clobetasol propionate (CBP), which resulted in marked epidermal thinning and depletion of interfollicular keratinocyte population. We found that a single exposure or chronic treatment with glucocorticoids (GCs) induced a strong increase in the expression of REDD1 (regulated in development and DNA damage response) mRNA and protein in mouse and human epidermis. REDD1 is a nutritional sensor and a stress-inducible inhibitor of mTOR complex 1, critical for protein synthesis regulation. Accordingly, we also noted a strong decrease in phospho-mTORS2448 expression in epidermis after exposure to GCs. We identified several molecular mechanisms for glucocorticoid control of REDD1 expression and function in epidermis. REDD1 is a primary target gene for glucocorticoid receptor (GR), whose expression is regulated via GR binding sites in the REDD1 promoter. We observed that GCs strongly induced expression of TXNIP (thioredoxin-interacting protein) that binds to and stabilizes REDD1 protein. We also observed down regulation of conservative miRNA-221 that regulates REDD1 expression. Most importantly, REDD1 knockout animals appeared resistant to epidermal atrophy induced by GCs. Finally, we revealed an excellent correlation between REDD1 induction in skin and individual animal sensitivity to adverse effects of topical steroids. Collectively, our findings reveal a novel mechanism of glucocorticoidinduced skin atrophy and link glucocorticoids to the control of protein synthesis in keratinocytes via mTOR regulation. In addition, our findings are relevant to the development of selective GR activators that have safer therapeutic profiles than classical steroids.
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Activation of nutritional sensor REDD1 is necessary for the development of steroid-induced cutaneous atrophy E Lesovaya, 1 G Baida, 2 R Lavker, 2 P Bhalla, 2 K Kirsanov, 2 M Yakubovskaya 1 and I Budunova 2 1 Chemical Carcinogenesis, Blokhin Cancer Research Center RAMS, Moscow, Russian Federation and 2 Dermatology, Northwestern University, Chicago, IL One of the major adverse effects of topical glucocorticoids is cutaneous atrophy. The molecular mechanisms underlying this phenomenon are poorly understood. To elucidate the mechanisms of epidermal hypoplasia, we used chronic topical treatment of mouse and human skin with glucocorticoids fluocinolone acetonide (FA) and clobetasol propionate (CBP), which resulted in marked epidermal thinning and depletion of interfollicular keratinocyte population. We found that a single exposure or chronic treatment with glucocorticoids (GCs) induced a strong increase in the expression of REDD1 (regulated in development and DNA damage response) mRNA and protein in mouse and human epidermis. REDD1 is a nutritional sensor and a stress-inducible inhibitor of mTOR complex 1, critical for protein synthesis regulation. Accordingly, we also noted a strong decrease in phospho-mTORS2448 expression in epidermis after exposure to GCs. We identified several molecular mechanisms for glucocorticoid control of REDD1 expression and function in epidermis. REDD1 is a primary target gene for glucocorticoid receptor (GR), whose expression is regulated via GR binding sites in the REDD1 promoter. We observed that GCs strongly induced expression of TXNIP (thioredoxin-interacting protein) that binds to and stabilizes REDD1 protein. We also observed down regulation of conservative miRNA-221 that regulates REDD1 expression. Most importantly, REDD1 knockout animals appeared resistant to epidermal atrophy induced by GCs. Finally, we revealed an excellent correlation between REDD1 induction in skin and individual animal sensitivity to adverse effects of topical steroids. Collectively, our findings reveal a novel mechanism of glucocorticoidinduced skin atrophy and link glucocorticoids to the control of protein synthesis in keratinocytes via mTOR regulation. In addition, our findings are relevant to the development of selective GR activators that have safer therapeutic profiles than classical steroids.
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Raptor increase and loss of Akt1 activity impairs filaggrin processing, a novel therapeutic avenue in atopic dermatitis A Naeem, 1 Atopic Dermatitis (AD) is a chronic inflammatory disease characterised by pruritus, eczematous lesions, increased transepidermal water loss and lichenification, Current treatments treat the immune response with little or no consideration of the cause of disease. Current evidence suggests that the primary defect is one of impaired barrier function, with mutations in the filaggrin gene being important. However not all AD patients have filaggrin mutations, suggesting that other mechanisms give rise to the barrier defect observed in AD patients. In support of this, we have detected loss of Akt1 activity in AD patients. We have previously reported that Akt1 activity is critical to the formation of the cornified envelope To further investigate the role of Akt1 in cornified envelope formation, we knocked down Akt1 expression using siRNA in Rat Epidermal Keratinocytes (REK), and created an organotypic culture model that phenocopies AD. Inhibition of Raptor, a component of rapamycinsensitive mTOR complex 1 (mTORC1) increases Akt1 activity. To determine the role of Raptor in modulating Akt activity, we overexpressed Raptor in REKs. The Akt1 knock down organotypic cultures showed the basket-weave hyperkeratosis characteristic of AD. Filaggrin localisation was altered and processing to the monomeric form greatly reduced as a result of increased interaction between the molecular charapone HspB1(Hsp27) and actin during terminal differentiation. In Raptor over expressing REKs we observed a dose dependent decrease in Akt activity and reduced filaggrin processing. Treatment with Rapamycin restored Akt activity and filaggrin processing. Therefore we describe a new pathway in atopic dermatitis, through Raptor and AKT1 that can lead to misprocessing of filaggrin and barrier defects. Furthermore these data suggest that Rapamycin, by inhibiting Raptor, could be a novel potential therapeutic avenue in atopic dermatitis without filaggrin mutations.
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Embryonic hyperactivation of the EGFR expands a hair follicle stem cell pool and causes hyperplasia of sebaceous glands M Dahlhoff and MR Schneider Institute of Molecular Animal Breeding and Biotechnology, Munich, Germany Dahlhoff M, Schneider MR Institute of Molecular Animal Breeding and Biotechnology, Gene Center, LMU Munich, Munich, German The role of epigen, the last identified ligand of the epidermal growth factor receptor (EGFR), remains largely unknown. We employed a doxycycline-inducible, skin-specific system to overexpress epigen in transgenic mice. Induction of epigen expression before epidermal stratification and hair follicle morphogenesis (E11.5) resulted in thickened epidermis, enlarged sebaceous glands, and increased sebum levels. The sebaceous gland phenotype fully regressed within a few weeks following doxycycline removal but renewed administration resulted in its re-emergence. When crossed into the EgfrWa5/+ background, a mouse line carrying a dominant negative EGFR, the sebum levels of epigen-overexpressing animals returned to the levels of control animals, indicating that the phenotype is largely EGFR-dependent. Surprisingly, postponing the induction of epigen expression to later developmental stages resulted in significantly weaker effects, while induction in adult mice failed to evoke any phenotypical alteration. LRIG1 marks a specific adult stem cell population in the junctional zone of the hair follicle which supplies the sebaceous gland and the interfollicular epidermis with new progenitor cells. LRIG1 transcripts were significantly increased in the skin of transgenic mice receiving doxycycline from early embryonic stages, but not in the skin of animals in which transgene expression was initiated only at adulthood. In accordance, immunofluorescence revealed a marked increase in the number of LRIG1-positive cells in the sebaceous gland and the junctional zone of the hair follicles in transgenic animals receiving doxycycline from early embryonic stages. We are currently investigating the expression of other genes encoding known markers of the hair follicle stem cell pool. Our data indicate that early activation of the EGFR can expand a stem cell population of the hair follicle and cause hyperplasia of skin compartments that depend on this pool. The skin is a multilayered epithelium that protects organisms from external challenges such as UV radiation. Changes in sun bathing behaviour and decreased UV shielding in the ozone layer have led to a steep increase in skin cancer incidences worldwide. UV-induced persistent DNA damage is a primary cause for carcinogenic mutations and tumour permissive systemic immune suppression. We have recently shown that persistent transcription blocking lesions lead to attenuation of IGF-1R signalling and increased cellular resistance to oxidative stress. Moreover, epidermal loss of IGF-1R signalling reduced proliferative potential and antagonized hyperplasia induced by a carcinogenic stimulus. Here we asked how epidermal IGF-1R signalling regulates acute and long term UVB response and if reduced IGF-1R signalling induces stress resistance using mice with an epidermal specific deletion of the IGF-1R (IGF-1Repi-/-). Although these mice have a thinner epidermis, this did not result in an increased amount of DNA damage after UVB irradiation. However, IGF-1Repi-/-mice were more susceptible to UVB-induced apoptosis. Surprisingly, despite this initial increase in cell death, these mice later showed an enhanced and sustained hyperproliferative response upon UVB radiation, as judged by interfollicular epidermal thickness and BrdU positive cells. This is in contrast to the requirement of IGF-1R during epidermal development when loss of IGF-1R counteracts growth and proliferative potential. Initial analysis revealed an increase in activation of the stress kinase p38 and increased stability of p53. Together, the data suggest that reduced IGF-1R signalling may confer increased stress resistance upon UVB radiation resulting in an increased hyperproliferative response and indicate that depending on the circumstances epidermal IGF-1R signalling confers either growth inhibitory or growth stimulatory responses. o also induced a NFATdependent luciferase reporter which was impaired by DES, expression of Orai1 R91W and inhibition of calcineurin using cyclosporine A (CsA). Using three-dimensional (3D) chemotactic migration assays, LPA-induced cell motility was significantly impaired by STIM1 knockdown, CsA and NFAT2 knockdown. LPA-induced migration assessed by a 2D scratch-wounding was also significantly impaired by CsA. Together, these data indicate that LPA induces SOCE through Orai1 channels leading to NFAT activation and promotes cell migration through a calcineurin/NFAT2 dependent pathway. Our study underscores the importance of Ca 2+ and NFAT signalling in the control of keratinocyte migration and wound healing.
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Neurotrophic stimulation of aged fibroblasts improves TGF-β expression and ECM remodeling in a dermal equivalent model C Golebiewski, P Prouheze, J Nicolaÿ and M Frechet Exsymol, Monaco, Monaco macroscopically by wrinkles and loss of elasticity, resulting from two critical processes: destruction of matricial proteins associated to the absence of deposition of newly synthesised proteins. Transforming Growth Factor beta (TGF-β) involved in the maintenance of connective tissue homeostasis, is a key messenger at the crossroad between ECM and cells, also well-known for being a collagen I and elastin stimulator. It is recognized as the most significantly altered signaling pathway in aging. Besides, it was reported that neurotrophic proteins and more specifically Nerve Growth Factor (NGF), also take a part in the preservation of skin homeostasis by regulating growth and survival of keratinocytes and fibroblasts. To investigate the relationship between NGF signaling, TGF-β production in human dermal fibroblasts (HDF) and ECM remodeling in aged skin, we made dermal equivalents (free-floating lattices) with serum-deprived HDF to model aged-related metabolic decline and consequences on ECM. These "aged" HDF expressed less TGF-β and pro collagen I as compared to HDF cultivated in optimum condition ("young" phenotype). We found that addition of NGF to "aged" HDF increased both TGF-β and pro-collagen I production. In line with this finding, addition of NGF to dermal equivalents containing "aged" fibroblasts enhanced contraction. Accordingly, addition of exogenous TGF-β also improved contraction of "aged" dermal equivalents. These results support the participation of NGF signaling in ECM remodeling with ECM protein content and cellmatrix interactions improvement. Finally, a synthetic molecule endowed with neurotrophic properties that potentiates NGF signaling, was tested in this model. This molecule could enhance TGF-β and collagen I expression and dermal equivalent contraction. Taken together, our results suggest that stimulation of neurotrophic signaling in the dermal compartment may limit wrinkle formation and elasticity loss occurring during skin aging.
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Autophagy suppresses the accumulation of p62/sequestosome-1 in the epidermis and in the thymic epithelium Autophagy is a tightly controlled process which delivers cellular components to the lysosome for degradation. Important functions of autophagy have been identified in multiple tissues, yet the role of autophagy in the epidermis and other epithelia is largely unknown. Here we have abolished autophagy in keratin K14-expressing epithelia and studied the molecular consequences. Mice carrying floxed alleles of ATG7, an essential regulator of macroautophagy, were crossed with mice expressing the Cre recombinase under the control of the K14 promoter to suppress autophagy in all K14-positive cells and in tissues derived from K14-positive precursors, such as the thymic epithelium. Western blot analysis of LC3 and fluorescence detection of the recombinant green fluorescent protein (GFP)-LC3 reporter protein on autophagosomes showed that epidermal keratinocytes and thymic epithelial cells activate autophagy constitutively. This process was efficiently blocked by deletion of ATG7. Immunofluorescence and Western blot analyses revealed that the suppression of autophagy led to the accumulation of p62/sequestosome 1 (SQSTM1), a target of selective autophagy, in both epithelia. As p62 has critical roles in Nrf2 and nuclear factor kappa-B (NF-kB) signaling, our data point to an indirect involvement of ATG7-dependent autophagy in the control of epithelial stress responses.
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Oligosaccharide modification by GnT-V augments skin sclerosis through enhancing TGFβ signaling Oligosaccharide modification by N-acetylglucosaminyltransferase-V (GnT-V), that catalyses the formation of β1,6 GlcNAc (N-acetylglucosamine) branches on N-glycans, is thought to be associated with cancer growth and metastasis. Overexpression of GnT-V in cancer cells enhances the signaling of growth factors such as epidermal growth factor and transforming growth factor-β (TGFβ) by increasing galectin-3 binding to polylactosamine structures on receptor N-glycans. We previously reported a novel role for GnT-V in epidermal homoeostasis, particularly in hyper proliferative conditions. In this study, we found that a high expression of GnT-V was detected in fibroblasts in the skin sections from localized scleroderma patients. Thus we examined the role of GnT-V in proliferations of fibroblasts and dermal fibrosis using GnT-V-deficient (GnT-V KO) mice. In GnT-V KO mouse skin, dermal thickness and collagen content was slightly decreased compared with wildtype mouse skin. GnT-V KO mice were also resistant to bleomycin (BLM)-induced skin sclerosis as a result of decreases in expression of collagen type1A1. However, the expression of TGFβ1 by BLM injection was increased to the similar level as control mice. We further investigated the response to TGFβ treatment and found that phosphorylation of smad2/3 at 24 hours after addition of TGFβ (10ng/ml) was decreased in dermal fibroblasts derived from GnT-V KO mice compared with wildtype mice. Furthermore, proliferation of fibroblasts derived from GnT-V KO mice was significantly decreased. These findings suggest that dermal fibrosis is impaired in GnT-V KO mice in part through reduced response to TGFβ treatment. Taken together, our findings suggest a possible role of oligosaccharide modification with GnT-V in the progression of dermal fibrosis such as localized scleroderma and allergic remodeling. It has been recently reported that EBS patients with the severe Dowling-Meara phenotype have an increased cumulative risk for BCC development after the age of 40. Using 3 previously described EBS-DM patient-derived and 2 control keratinocyte cell lines we tested their DNA damage response mechanisms after exposure to ionizing radiation (IR). Cell metabolic activity was measured before and after exposure to IR, and followed up to 7 days after treatment. All cell lines showed a marked decrease in metabolic activity till the 4th day. While control cells recovered between the 4th and 7th day, the EBS-DM cells still displayed low cell count (10-50% of plated cells) and low metabolic activity (50% of initial values). Using protein microarrays we tested 500 proteins with a key role in MAPK signaling, the cell cycle, apoptosis, the DNA damage response and gene regulation, and 46 proteins in the EBS-DM mutant had significantly altered expression levels. These involved components of the death receptor pathway, apoptosis and DNA damage response. Because of the known interplay between these pathways it is difficult to predict their biological consequences to EBS-DM keratinocytes, so we tested EBS-DM (and control) keratinocytes' sensitivity to TRAIL and TNF treatment. Normally, a decrease in metabolic activity would be expected after treatment. However, all 3 severe EBS-DM cell lines displayed lower sensitivity to death receptor ligands. Our data suggests that to overcome the consequences of severe keratin (5 or 14) mutations, EBS-DM keratinocytes adjust their metabolism so that they also acquire traits of cancer cells. In this context, it is plausible that when DNA damage mechanisms fail, EBS-DM keratinocytes may become more susceptible to malignant transformation. 2+ (eCa) from low (0.05mM) to high (1.4mM). Likewise, VitD effects on cell number and lipid synthesis of SZ95 sebocytes were evaluated. The increase of eCa concentration from 0.05 to 1.4mM over 24 h significantly increased SZ95 sebocyte numbers up to 43±10% in a Ca 2+ level-dependent manner (p<0.01), whereas eCa decrease from 1.4 to 0.05mM did not influence cell numbers. On the other hand, eCa concentration (0.05-0.2mM) was critical for lipid synthesis, since a eCa raise decreased significantly cellular neutral lipids and membrane polar lipids and a eCa reduction increased neutral and polar lipids over 24h. Ultrastructural features of lipogenesis, such as increased Golgi components and lipid droplets were observed at a low eCa concentration. Ca 2+ chelation by ethylene glycol tetraacetic acid did not influence SZ95 sebocyte numbers after 24h of treatment but increased neutral (40±5%) and polar (26±6%) lipids. Likewise, addition of linoleic acid significantly decreased Ca 2+ -induced SZ95 sebocyte neutral lipids (p<0.001). In addition, cell apoptosis -assessed by detection of caspase 3/7 activity -was increased 1.9-to 2.1-fold by Ca 2+ removal as compared to 1.4mM extracellular calcium. VitD (1-100nM) significantly increased the numbers of SZ95 sebocytes maintained at slow growth conditions (up to 59±4%; p<0.05), whereas it significantly reduced sebocyte lipids (p<0.05). In conclusion, Ca 2+ and VitD exerted a regulatory function on SZ95 sebocytes in a reverse manner to that of epidermal keratinocytes; low eCa induced sebocyte differentiation, whereas high eCa and VitD inhibit terminal sebocyte differentiation in vitro.
www.jidonline.org S101 PKCs are involved in RIPK4-dependent signaling pathways C Rösselet, P De Groote, G Tanghe, B Gilbert, P Vandenabeele, S Lippens and W Declercq
Department of Molecular Biomedical Research, VIB-Ghent University, Ghent, Belgium
The Receptor Interacting Protein (RIP) kinases are a family of S/T kinases, generally involved in activation of the transcription factors NF-kappaB and AP-1. Deletion of RIPK4 in mice is perinatally lethal due to fusions of external orifices and due to defects in keratinocyte terminal differentiation. RIPK4 knockout mice largely phenocopy the defects observed in humans suffering from Bartsocas Papas syndrome. RIPK4 has originally been identified as a PKCβ1 and -δ interacting protein. We could recently show that RIPK4 can induce E-cadherin internalization. An important role of PKCs has been shown in the regulation of endocytosis and recycling of E-Cadherin. In this study we are investigating the possible role of PKCs in RIPK4-induced cell signaling. We used biochemical and molecular biology methods to assess whether PKCs are involved in RIPK4 signaling. We found that RIPK4 can interact with most PKC isoforms (α, βI, βII, γ, ε, η, ι, ζ) but can only be phosphorylated by PKC η and PKCε. Furthermore, PKCη -or PMA-induced NF-kB can be inhibited by co-expression of dominant-negative RIPK4 mutants suggesting that PKCs act upstream of RIPK4. We hypothesize that RIPK4 could be an important mediator of PKC-mediated functions in E-cadherin turnover. We previously identified the NK cell receptor KIR3DL2 as a valuable diagnostic and prognostic marker for the detection of the tumoral T cell burden of Sézary syndrome patients. However, the function of this receptor on the malignant T lymphocyte population remained unexplored. We demonstrate that triggering of KIR3DL2 with the specific mAb AZ158 results in a strong inhibition of the CD3-mediated proliferation and cell death of the CD4+ KIR3DL2+ cells. Unexpectedly, engagement of KIR3DL2 by its newly identified ligand CpG ODN-C does not promote the delivery of such negative signals. However, binding of CpG ODN-C to KIR3DL2 induces the internalization of the receptor and leads to a caspase-dependent apoptosis of the malignant T cells. This process of cellular death is correlated to a dephosphorylation of the transcription factor STAT3, which is found constitutively phosphorylated and activated in Sézary cells. Our results suggest that according to its mode of engagement (mAb versus ligand), KIR3DL2 can act as a co-inhibitory receptor or specifically promote Sézary syndrome malignant cell death.
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Cytoskeletal changes associated with psoriasis skin disease is dependent on a human tumorous imaginal disc1 S expression in keratinocytes of human psoriatic epidermis The biochemical mechanism by which human tumorous imaginal disc1 (hTid-1) interferes with actin cytoskeleton organization in psoriatic skin was investigated. Western blot analysis revealed that hTid-1, specifically hTid-1 S , interacts with MK5, a p38-regulated/activated kinase, in cultured HeLa cells. The binding of hTid-1 s with MK5 inhibits its protein kinase activity that phosphorylates heat shock protein HSP27 whose phosphorylation is known to play a critical role in the regulation of Factin polymerization. Overexpression of hTId-1 s results in the inhibition of actin cytoskeleton organization and cell migration in transfected HeLa cells. However, actin cytoskeleton organization as well as cell migration was enhanced in HeLa cells under hypoxic conditions induced by CoCl 2 treatment. We postulate that transcriptional down regulation of hTid-1 s under hypoxic conditions causes insufficient binding of hTid-1 s with MK5 to stimulate its kinase activity and HSP27 phosphorylation. Immunohistochemistry analysis has shown that the aberrant actin cytoskeleton organization in psoriatic skin epidermis correlates with the loss of hTid-1 expression in the basal layer of epidermis. The reciprocal relationship between hTid-1 s expression and HSP27 phosphorylation was reinforced by the Western blot analysis showing the reduced of hTid-1 s expression and enhanced HSP27 phosphorylation in lesional skin epidermis taken from patients with psoriasis disease than from normal controls. Important role of hTid-1 s downregulation on the etiological cause of psoriasis was further supported by the stimulation of actin cytoskeleton organization in cultured human keratinocytes expressing hTid-1 s .
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ZnO nanoparticles induce HIF-1α stabilization through the generation of reactive oxygen species from mitochondrial complex III (ZnO NPs) are widely used in commercial products, such as cosmetics, medicine, and electronics industries. It is known that ZnO NPs induce Reactive Oxygen Species (ROS) production, leading to cellular toxicity. ROS production plays a crucial role in hypoxiainducible factor-1α (HIF-1α) activation. This study therefore evaluated the mechanism of ROS generation and HIF-1α stabilization by ZnO NPs in human immortalized keratinocytes, HaCaT cells. ZnO NPs increased the ROS levels and enhanced ROS levels induced by ZnO NPs originated from complex III of the mitochondrial electron transport chain (ETC). ROS production from mitochondrial complex III is required for ZnO NPs-induced HIF-1α stabilization. ZnO NPs-induced ROS increased the expression of HIF-1α-dependent genes, such as VEGF. Our study investigated that ZnO NPs-induced ROS which was originated from complex III of mitochondrial ETC and ZnO NPs-induced ROS stabilized HIF-1α protein, leading to expression of HIF-1α target genes.
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Decreased expression of neuropeptides and their receptors in skin lesions of patients with mastocytosis JP Antoniewicz, 1 P Bieniasz-Krzywiec, 1 B Nedoszytko, 2 M Lange 2 and M Zmijewski 1 1 Histology, Medical University of Gdansk, Gdansk, Poland and 2 Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland Mastocytes (MC) as a unique cells of the immune system reside in peripheral tissues, including skin. MC are known to play essential role in development allergy and anaphylaxis. Morover, pathologic increase of MS number leads to a rare, heterogeneous group of diseases called mastocytosis. It`s most common form is cutaneous mastocytosis (CM), but internal organs such as bone marrow, liver, spleen and lymph nodes might be also affected resulting in systemic mastocytosis (SM). Very little is known about pathomechanism of the disease, thus we investigated expression of elements of hypothalamus-pituitary-adrenal axis (HPA) in skin lesions of CM patients. Corticotropin-releasing factor (CRF) and proopiomelanocortin (POMC) as initial elements of HPA axis not only regulate stress response but also proliferation of cells and pigment production. POMC-derived peptide -α-MSH was indicated as a triggering factor in development of urticaria pigmentosa -main symptom of CM. Here we are presenting our preliminary results showing decrease level of neuropeptides and related receptors in biopsies of urticaria pigmentosa. In comparison to healthy skin the statistical significant decreased levels of mRNA for CRF; urocortins 1,2 and 3; POMC; MC1R and MC4R receptors was observed in hyperpigmented skin lesions of CM and SM patents by real-time PCR. The lowest decrease was observed for POMC (4 fold) and the highest for MC4R (25 fold). The presented data suggest that immune response in skin lesion of mastocytosis patients might be not well regulated by local equivalent of HPA axis although this suggestion required further confirmation.
Phosphorylated Mammalian Target of Rapamycin is not frequently increased in human pemphigus vulgaris lesions AM Poot, H Eikmans, MF Jonkman and HH Pas Center for Blistering Diseases, Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
In pemphigus vulgaris (PV) auto-antibodies are directed against the desmosomal cadherins desmoglein 3 (Dsg3) and/or Dsg1. These auto-antibodies induce acantholysis in mucosa and skin. Whether signaling pathways are involved is a matter of debate. Recent studies linked the Mammalian target of Rapamycin (mTOR) pathway, a regulator of cell growth and proliferation, to acantholysis. Phosphorylated mTOR (p-mTOR) was increased in lesional mouse skin and its inhibition prevented acantholysis in a pemphigus mouse model. Our aim was to determine whether p-mTOR is increased in patient skin and in an in vitro pemphigus human skin model. We compared lesional with nonlesional skin sections from 5 mucocutaneous PV (mcPV) patients, and compared non-lesional skin sections of 4 mucosal PV patients (mPV) and 6 mcPV patients with 4 non-pemphigus controls. Furthermore, healthy skin biopsies were incubated for 24 hours with IgG isolated from PV and control patients. We visualized acantholysis by haematoxylin/eosin staining, p-mTOR by immunofluorescence microscopy, and used image analysis software for quantification. Phosphorylated mTOR was mainly located in the basal epidermal layer. Its levels varied considerably in our control group. Only one mcPV patient showed more p-mTOR in lesional skin compared to non-lesional PV skin, while 3 showed downregulation. Two mPV patients and 1 mcPV patient showed increased p-mTOR levels in non-lesional skin compared to control skin. In our in vitro skin model p-mTOR levels were not significantly higher in acantholytic skin compared to control skin. In conclusion, we found no clear association between increased p-mTOR levels and acantholysis, in vivo and in vitro. However mTOR phosphorylation could still be an early and transient event in acantholysis. Therefore we cannot definitely exclude mTOR as mediator of acantholysis in humans. Future studies should aim to investigate the effects of mTOR inhibitors on acantholysis in human skin.
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The There were studies assessing the relationship between acrochordons and HOMA-IR, insulin, fasting glucose and dyslipidemia. However, no study assessing insulin resistance at the tissue level has been conducted yet. The purpose of this study was to assess the metabolic disease indicators, the levels of IGF-1R and IGF-2R in the acrochordon tissue. Thirty patients with at least 1 acrochordon in their body who had no known history of diabetes mellitus and the control group comprised 30 individuals who had no acrochordon or no known history of diabetes mellitus were included. IGF-1R and IGF-2R receptor expression was investigated using immunohistochemical assessment administered to the tissue samples from the groups. In our study, BMI and insulin values in the group with acrochordon were found to be significantly higher compared to the control group (p=0,04 and p=0,031). No statistically significant difference was observed between the groups in terms of lipid profile (p>0,05). In the group with acrochordon, IGF-1R and IGF-2R expression was found to be significantly higher compared to the control group (p<0,01). IGF-1R expression was found to correlate with serum IGF-1 and BMI (p=0,03 r=0,028 and p=0,048 r=0,257 respectively). IGF-2R expression was found to correlate with 03 r=0, 357 and p=0, 046 r=0, 256 respectively) .Using the logistic regression analysis, an increase in serum insulin, serum IGF-1 and HOMA-IR levels increase the IGF-1R and IGF-2R expression rates was shown. These findings support the view that insulin metabolism disorders in patients with acrochordon should be evaluated. Our study indicates that IGF-1R and IGF-2R may have an effect on the acrochordon pathogenesis and that acrochordon etiology and related conditions can be clarified by detection of parameters that influence the receptor levels.
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Emerging role of alternative splicing in the skin neuroendocrinology MA Zmijewski Histology, Medical University of Gdansk, Gdansk, Poland Skin is constantly subjected to external and internal stressors, thus it is not surprising that it possess local and fully functional neuroendocrine system. The skin is respond to the stimuli by local expression of multiple neuropeptides, cytokines and hormone, which act as autocrine, paracrine and at least in some cases endocrine signals. Those regulatory molecules may affect target cells thought the interaction with membrane-bound or nuclear receptors and regulate their proliferation, activity and immune properties. The majority of human genes including those for receptors code several protein variants contributing to the genomic variability. This is also the case of the corticotropinreleasing factor (CRF) and its receptors (CRF1 and CRF2) are the initiatory elements of hypothalamic-pituitary-adrenal axis (HPA) -the central mechanism of stress response. Both CRF receptors were found to be expressed in various numbers of isoforms in the human and rodent skin. As shown for CRF1 the pattern of expressed isoforms changes with age of culture and is regulated by environmental factors such as ultraviolet radiation. As predicted by molecular modeling only some isoforms (CRF1α, β and c) showed proper cell membrane localization. Others maintained in the cell (CRF1d, f and g) or were found to be soluble (CRF1e and h). Moreover, presence of alternative isoforms influenced trafficking, localization and activity of main isoform -CRF1α, as shown of HaCaT keratinocyte model with co-expression various CRF1 isoforms. Because, alternative splicing of mRNA is common feature of majority of membrane-bound and nuclear receptors this model may be extended and form additional level of regulation of activity of multiple receptors. The possible mechanisms include dimerization, decrease of affinity to ligands, modulation of interaction with G-proteins, fast mRNA decay and decoy receptor. Moreover, neuropeptides and hormones are implicated in the pathogenesis of several human skin diseases suggesting potential rule of alternative splicing in their development and could represent an additional target for drugs design.
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Mitogen and stress-activated kinase 1 activation is impaired in psoriatic keratinocytes in response to mechanical stress AM Brown, C Todd, H Darlington, NJ Reynolds and J Reichelt Institute of Cellular Medicine, Newcastle University, Newcastle, United Kingdom The aim of our study was to investigate whether psoriatic keratinocytes show increased susceptibility to mechanical stress. We isolated and expanded keratinocytes from biopsies of uninvolved skin from psoriasis patients and control individuals and used the Flexcell system to stretch these keratinocytes in culture. We used Western blotting and phosphorylation-specific antibodies to analyse activation of mitogen-activated protein (MAP) kinase signalling pathways upon stretch. Psoriasis is a disabling skin disease affecting approximately 2% of the Western population. It is characterised by abnormal cellular proliferation giving rise to areas of raised scaly skin, or "plaques". Psoriatic plaques characteristically localize to knees and elbows, skin regions that are particularly subject to mechanical stress. Moreover, 30-50% of patients develop plaques at sites of trauma, known as the Koebner phenomenon. Most cell types in vivo, as well as in culture, respond to mechanical stress with increased cell proliferation. Activation of MAP kinases has been shown to play key roles in mechanosignalling. MAP kinase signalling pathways have been shown to be dysregulated in psoriasis, with MAP kinase ERK1/2 and p38 activation increased in lesional psoriatic skin. In line with previous observations we detected activation of p38 MAP kinase signalling and activation of the downstream kinase mitogen and stress-activated kinase 1 (MSK1) in normal human keratinocytes in response to mechanical stress. Whereas p38 activation was similar in normal and psoriatic keratinocytes, our results revealed that MSK1 was not activated in psoriatic keratinocytes in response to mechanical stretch. MSK1 is known to stimulate the production of anti-inflammatory cytokines and can thus act as negative regulator of inflammation. Our data suggest an involvement of MSK1 regulation in the pathogenesis of psoriasis. MSK1 may thus represent a novel therapeutic target. Confocal Raman Spectroscopy allows to obtain precise information about molecular skin composition. This technique is a useful tool to determine depth profiles of water and NMF concentration in the skin. In this study Raman Spectroscopy was used to examine the ability of cosmetic ingredients to penetrate through the stratum corneum to the epidermis. Experiments were carried out in four steps. First, the reference spectra of two anti-wrinkle peptides (three to five amino acids) and recombinant Growth Factor (GF) were determined at the depth of 450 and 15 -25 μm respectively. Second, the study of pure active substances penetration, applied on the skin explants, were investigated. Moreover, study of the penetration ability of GF from the emulsion o/w and w/o, as well as it's encapsulated forms were performed. Generated reference spectra for both anti-wrinkle peptides showed their penetration through the stratum corneum into the dermis to the depth of 450 μm, whereas recombinant GF did not. Also GF added to cosmetic formulations W/O and O/W did not migrate through stratum corneum. However, depending on encapsulating forms, the tested compound was able to migrate through the skin to the depth of 20 μm. Penetration abilities of cosmetic substances is crucial for their proper activity in the skin and plays an important role in designing products for personal care in the cosmetic industry. This study demonstrated that the Raman Spectroscopy is a useful technique to test penetration abilities through the stratum corneum of active substances used in cosmetic formulations.
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Expression of activating transcription factor3 in related to the biologic behavior of cutaneous squamous cell carcinoma S Choi and S Chang 1Department of Dermatology, Asan Medical Center, Seoul, Republic of Korea Seok Joo Choi, Sung Eun Chang Department of Dermatology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea Activating transcription factor3 a member of the ATF,cyclic AMP response element-binding family of transcription factors, is an adaptive response gene that plays an oncogenic role in the development of various cancers. To our knowledge, little information is available on the possible role of ATF3 in skin cancer. In this study, we investigated the expression of ATF3 in basal cell carcinomas, actinic keratosis, squamous cell carcinomas and Bowen's disease via immunohistochemistry. In results, no ATF3 expression was detected in normal skin and BCCs. Immunohistochemical analyses revealed ATF3 expression in SCCs, suggesting that the protein is involved in the pathogenesis of SCCs, but not BCCs. In addition, higher expression of ATF3 was observed in metastatic SCCs and SCCs in organ transplant recipients. Thus, ATF3 appears to play an oncogenic role in the development of SCCs and is related to biologic behavior of SCCs.
